Skip to main content
SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD logo

SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000078 ISIN · CNE000000X95 LEI · 300300J4GCOV7CYQTB51 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,619 across all filing types
Latest filing 2020-07-13 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000078

About SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD

https://www.neptunusbio.com

Shenzhen Neptunus Bioengineering Co., Ltd. is a comprehensive healthcare enterprise focused on the research, development, manufacturing, and distribution of pharmaceutical products. The company operates across the entire industry value chain, including the production of chemical drugs, biological preparations, and traditional Chinese medicines. Its portfolio extends to medical devices and health supplements. A significant component of its operations involves a large-scale pharmaceutical distribution network and a nationwide retail pharmacy chain. The company emphasizes innovation in biotechnology and maintains modern production facilities to support its diverse product lines. By integrating R&D with a robust logistics and retail infrastructure, it provides a wide range of healthcare solutions to medical institutions and consumers.

Recent filings

Filing Released Lang Actions
关于召开2020年第二次临时股东大会的提示性公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement about the convening of the 2020 second extraordinary general meeting (临时股东大会) of Shenzhen Haier Bioengineering Co., Ltd. It includes information about the meeting date, voting procedures (including online voting), agenda items, registration methods, and proxy authorization forms. There is no financial data, earnings information, or management discussion of results. The document is not a report itself but an announcement and instructions related to a shareholder meeting. It does not contain voting results or final decisions, so it is not a Declaration of Voting Results (DVA). It is not a Proxy Solicitation (PSI) because it does not solicit votes but informs about the meeting and voting process. The document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the meeting and voting procedures without being the meeting materials or results themselves.
2020-07-13 Chinese
关于按期偿还公开发行及非公开发行公司债的自愿性信息披露公告
Capital/Financing Update Classification · 95% confidence The document is a voluntary disclosure announcement regarding the timely repayment of publicly and non-publicly issued corporate bonds by Shenzhen Haier Bioengineering Co., Ltd. It details the bond issuance dates, amounts, interest rates, and confirms full repayment of principal and interest. The document does not contain detailed financial statements or comprehensive financial analysis but serves as an update on the company's financing activities and capital structure. It is not an annual or interim report, audit report, or earnings release. The content fits best under Capital/Financing Update (CAP) as it provides information on bond repayments and financing status.
2020-07-03 Chinese
关于召开2020年第二次临时股东大会通知的公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice for convening the 2020 second extraordinary general meeting of shareholders of Shenzhen Haiwang Bioengineering Co., Ltd. It includes details about the meeting time, location, agenda items (such as extending the validity of a non-public stock issuance resolution), voting procedures, and proxy authorization forms. There are no financial statements or detailed financial data presented. The document is primarily an announcement informing shareholders about the meeting and how to participate, including voting instructions and proxy forms. It does not contain the results of the vote or the meeting minutes. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2020-06-30 Chinese
独立董事关于第八届董事局第九次会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding matters to be discussed at a board meeting, specifically about extending the validity of a non-public stock issuance resolution and related authorization, as well as approval of related party transactions (property leasing). It references governance and regulatory guidelines but does not contain financial statements or detailed financial results. The document is short (717 characters) and is essentially a board/management communication about internal company decisions and approvals. Therefore, it fits best under Board/Management Information (MANG).
2020-06-29 Chinese
第八届董事局第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the ninth meeting of the eighth board of directors of Shenzhen Haiwang Bioengineering Co., Ltd. It details the meeting date, attendance, voting results, and specific agenda items such as extending the validity of a non-public stock issuance resolution and authorizing the board to handle related matters. The document does not contain financial statements or detailed financial analysis but rather reports on board decisions and governance matters. It is not an annual report, earnings release, or financial supplement. It is not a proxy solicitation or voting results announcement but a board meeting resolution announcement. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and focused on board resolutions, confirming this classification with high confidence.
2020-06-29 Chinese
2019年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2019 Annual General Meeting Resolution Announcement" for Shenzhen Haier Bioengineering Co., Ltd. It details the date and method of the meeting, attendance, voting results on various proposals including the 2019 annual board report, supervisory board report, financial report, profit distribution plan, and the full annual report. The document primarily reports the voting results and resolutions passed at the 2019 Annual General Meeting (AGM). It does not contain the full annual report or detailed financial statements but rather the official announcement of the AGM resolutions and voting outcomes. The document length is 4686 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-06-29 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.